Skip to main content
SpringerLink
Log in

Aktuelle Aspekte der Langzeittherapie bei Schizophrenie

  • Conference paper
Aktuelle Aspekte der Pathogenese und Therapie der Schizophrenie

  • 1102 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adams CE, Fenton MKP, Quraishi S, David AS (2001) Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry 179: 290–299

    Article  PubMed  CAS  Google Scholar 

  • Carpenter WT, Buchanan RW, Kirkpatrick B, Breier AF (1999) Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 156: 299–303

    PubMed  Google Scholar 

  • Cheung HK (1981) Schizophrenics fully remitted on neuroleptics for three-five years: to stop or continue drugs? Br J Psychiatry 138: 490–494

    PubMed  CAS  Google Scholar 

  • Crow TJ, MacMillan JF, Johnson AL, Johnstone EC (1986) A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 148: 120–127

    PubMed  CAS  Google Scholar 

  • Csernansky, JG, Bellows, EP, Barnes, DE, Lombrozo, L (1990) Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmacology 101: 519–524

    Article  PubMed  CAS  Google Scholar 

  • Csernansky JG, Mahmoud R, Brenner R (2002) A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 346: 16–22

    Article  PubMed  CAS  Google Scholar 

  • Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60: 553–564

    Article  PubMed  CAS  Google Scholar 

  • Davis J, Schaffer C, Killian G, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6: 70–87

    PubMed  CAS  Google Scholar 

  • Gaebel W, Janssen B, Riesbeck M (2003) Modern treatment concepts in schizophrenia. Pharmacopsychiatry 36[Suppl 3]: 168–175

    Google Scholar 

  • Gaebel W, Möller H-J, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, von Wilmsdorff W, Bottlender R, Klingberg S (2004) Pharmacological long-term treatment strategies in first episode schizophrenia. Study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia. Eur Arch Psychiatry Clin Neurosci 254: 129–140

    Article  PubMed  Google Scholar 

  • Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS (2005) Schizophrenia practice guidelines — an international survey and comparison. Br J Psychiatry (im Druck)

    Google Scholar 

  • Gaebel W, Jänner M, Frommann N, Pietzcker A, Köpcke W, Linden M, Müller P, Müller-Spahn F, Tegeler J (2002) First vs. multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophr Res 53: 145–159

    Article  PubMed  Google Scholar 

  • Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systemic overview and meta-regression analysis. BMJ 32: 1371–1376

    Article  Google Scholar 

  • Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M (2001) Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry 158: 1835–1842

    Article  PubMed  CAS  Google Scholar 

  • Glenthoj B, Hemmingsen R, Allerup P, Bolwig, TG (1990) Intermittent vs. continuous neuroleptic treatment in a rat model. Eur J Pharmacol 190: 275–286

    Article  PubMed  CAS  Google Scholar 

  • Herz MI, Lamberti JS, Mintz J, Scott R, O’Dell SP, McCartan L, Nix G (2000) A program for relapse prevention in schizophrenia. Arch Gen Psychiatry 57: 277–283

    Article  PubMed  CAS  Google Scholar 

  • Hogarty GE, Goldberg SC (1973) Drugs and sociotherapy in the aftercare of schizophrenic patients: one-year relapse rates. Arch Gen Psychiatry 28: 54–64

    PubMed  CAS  Google Scholar 

  • Hogarty GE, Goldberg SC, Ulrich RF (1974) Drugs and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. Arch Gen Psychiatry 31: 603–608

    PubMed  CAS  Google Scholar 

  • Hogarty GE, Schooler NR, Ulrich RF, Mussare F, Ferro P, Herron E (1979) Fluphenazine and social therapy in the aftercare of schizophrenic patients: relapse analysis of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Arch Gen Psychiatry 36: 1283–1294

    PubMed  CAS  Google Scholar 

  • Hogarty GE, Ulrich RF (1998) The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions to psychsocial treatment. J Psychiatr Res 32: 243–250

    Article  PubMed  CAS  Google Scholar 

  • Hogarty GE, Ulrich RF, Mussare F, Arishgueta N (1976) Drug discontinuation among long term, successfully maintained schizophrenic outpatients. Dis Nerv Syst 37: 494–500

    PubMed  CAS  Google Scholar 

  • Jeste DV, Potkin SG, Sinha S, Feder SL, Wyatt RJ (1979) Tardive dyskinesia — reversible and persistent. Arch Gen Psychiatry 36: 585–590

    PubMed  CAS  Google Scholar 

  • Johnson DAW (1979) Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. Br J Psychiatry 135: 524–530

    Article  PubMed  CAS  Google Scholar 

  • Kane JM (1996) Schizophrenia. N Engl J Med 334: 34–41

    Article  PubMed  CAS  Google Scholar 

  • Kane JM (2003) Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies. J Clin Psychiatry 64[Suppl 16]: 34–40

    PubMed  Google Scholar 

  • Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J (1982) Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry 21: 82–86

    Google Scholar 

  • Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J (American Psychiatric Association Steering Committee on Practice Guidelines) (2004) Practice guideline for the treatment of patients with schizophrenia, 2nd edn. Am J Psychiatry 161[Suppl 2]: 1–56

    PubMed  Google Scholar 

  • Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM (2003a) Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 160: 1209–1222

    Article  PubMed  Google Scholar 

  • Leucht S, Wahlbeck K, Hamann J, Kissling W (2003b) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361: 1581–1589

    Article  PubMed  CAS  Google Scholar 

  • Lieberman JA, Tollefson D, Tohen M, Green AI, Gur RE, Kahn R, McEveoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM and The HDGH Study Group (2003) Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 160: 1396–1404

    Article  PubMed  Google Scholar 

  • McCreadie RG, Wiles D, Grant S, Crockett GT, Mahmood Z, Livingston MG, Watt JA, Greene JG, Kershaw PW, Todd NA, et al (1989) The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group. Acta Psychiatr Scand 80: 597–602

    PubMed  CAS  Google Scholar 

  • McGorry P, Killackey E, Elkins K, Lambert M, Lambert T (2003) Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia. Australasian Psychiatry 11: 136–147

    Article  Google Scholar 

  • National Institute for Clinical Excellence (NICE) (2002) Clinical Guideline 1: Schizophrenia — Core interventions in the treatment and management of schizophrenia in primary and secondary care (www.nice.org.uk)

    Google Scholar 

  • Robinson D Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56: 241–247

    Article  PubMed  CAS  Google Scholar 

  • Rummel C, Hamann J, Kissling W, Leucht S (2003) New generation antipsychotics for first episode schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 4. Wiley, Chichester

    Google Scholar 

  • Schooler N, Davidson M, Kopala L (2003) Reduced relapse rates in recent onset schizophrenia patients treated with rsiperidone vs. haloperidol. Eur Neuropsychpharmacol 13[Suppl 4]: S337

    Article  Google Scholar 

  • Wölwer W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, Gaebel W (2003) German research network on schizophrenia — bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 253: 321–329

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Heinrich-Heine-Universität Düsseldorf — Rheinische Kliniken Düsseldorf, Bergische Landstraße 2, 40629, Düsseldorf, Bundesrepublik Deutschland

    Prof. Dr. W. Gaebel & M. Riesbeck

Authors
  1. Prof. Dr. W. Gaebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Riesbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Gaebel .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie-Innenstadt, Klinikum der Universität München, Nußbaumstraße 7, 80336, München, Deutschland

    Hans-Jürgen Möller  & Norbert Müller  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this paper

Cite this paper

Gaebel, W., Riesbeck, M. (2006). Aktuelle Aspekte der Langzeittherapie bei Schizophrenie. In: Möller, HJ., Müller, N. (eds) Aktuelle Aspekte der Pathogenese und Therapie der Schizophrenie. Springer, Vienna. https://doi.org/10.1007/3-211-29109-1_10

Download citation

  • DOI: https://doi.org/10.1007/3-211-29109-1_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-29043-9

  • Online ISBN: 978-3-211-29109-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation